FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3081917032> ?p ?o ?g. }

• W3081917032 endingPage "361" @default.
• W3081917032 startingPage "356" @default.
• W3081917032 abstract "PurposeIn February 2020, the COVID-19 pandemic reached the United States. The impact of the pandemic on the US radiation oncology field remains unknown. The American Society for Radiation Oncology surveyed US radiation oncology practice leaders to gauge initial impact and immediate operational responses to the pandemic.Methods and MaterialsFrom April 16 to April 30, 2020, the American Society for Radiation Oncology surveyed US radiation oncology practice leaders by email to gauge initial impact and immediate operational responses to the COVID-19 pandemic.ResultsTwo hundred twenty-two (43%) of 517 leaders responded from community and academic practices (62% and 34%, respectively), hospital-based and free-standing centers (69% and 29%), and metro and rural locations (88% and 12%). Practices reported treating an average of 1086 patients per year in 2019 (range, 0-7900) with an average daily treatment volume of 70 patients (range, 5-400). All practices reported uninterrupted operation. On average, practices were treating 68% of their typical volume (range, 10%-95%), with 92% implementing planned treatment postponement for lower risk patients. An estimated revenue decrease of 20% or more was experienced by 71% of practices. Confirmed COVID-19 patient cases were treated by 39% of practices. Seventy percent experienced staff shortages. Almost all (98%) practices implemented formal operational procedures to protect patients and staff, although personal protective equipment/infection control supply shortages were reported by 78% of practices. Seventy-four percent used telemedicine for virtual follow-up surveillance, and 15% leveraged telemedicine for on-treatment assessment.ConclusionsThe clinical and financial impacts of the COVID-19 pandemic on US radiation oncology were deep and broad. Despite reported shortages in personal protective equipment, declines in revenue, and reduced patient volumes, practices adapted quickly by refining standard processes of care, implementing recommended safety measures, and employing telemedicine to facilitate treatment continuity. Patients with higher risk disease experienced uninterrupted access to care. We plan to continue regular surveying across the lifespan of the pandemic to document the geographic and temporal impact of COVID-19 on the field and its patients. In February 2020, the COVID-19 pandemic reached the United States. The impact of the pandemic on the US radiation oncology field remains unknown. The American Society for Radiation Oncology surveyed US radiation oncology practice leaders to gauge initial impact and immediate operational responses to the pandemic. From April 16 to April 30, 2020, the American Society for Radiation Oncology surveyed US radiation oncology practice leaders by email to gauge initial impact and immediate operational responses to the COVID-19 pandemic. Two hundred twenty-two (43%) of 517 leaders responded from community and academic practices (62% and 34%, respectively), hospital-based and free-standing centers (69% and 29%), and metro and rural locations (88% and 12%). Practices reported treating an average of 1086 patients per year in 2019 (range, 0-7900) with an average daily treatment volume of 70 patients (range, 5-400). All practices reported uninterrupted operation. On average, practices were treating 68% of their typical volume (range, 10%-95%), with 92% implementing planned treatment postponement for lower risk patients. An estimated revenue decrease of 20% or more was experienced by 71% of practices. Confirmed COVID-19 patient cases were treated by 39% of practices. Seventy percent experienced staff shortages. Almost all (98%) practices implemented formal operational procedures to protect patients and staff, although personal protective equipment/infection control supply shortages were reported by 78% of practices. Seventy-four percent used telemedicine for virtual follow-up surveillance, and 15% leveraged telemedicine for on-treatment assessment. The clinical and financial impacts of the COVID-19 pandemic on US radiation oncology were deep and broad. Despite reported shortages in personal protective equipment, declines in revenue, and reduced patient volumes, practices adapted quickly by refining standard processes of care, implementing recommended safety measures, and employing telemedicine to facilitate treatment continuity. Patients with higher risk disease experienced uninterrupted access to care. We plan to continue regular surveying across the lifespan of the pandemic to document the geographic and temporal impact of COVID-19 on the field and its patients." @default.
• W3081917032 created "2020-09-08" @default.
• W3081917032 creator A5002414848 @default.
• W3081917032 creator A5004497069 @default.
• W3081917032 creator A5005511224 @default.
• W3081917032 creator A5012879447 @default.
• W3081917032 creator A5041542657 @default.
• W3081917032 creator A5044074623 @default.
• W3081917032 creator A5058872602 @default.
• W3081917032 creator A5083316273 @default.
• W3081917032 creator A5085642819 @default.
• W3081917032 creator A5086367306 @default.
• W3081917032 date "2020-10-01" @default.
• W3081917032 modified "2023-10-17" @default.
• W3081917032 title "Initial Impact and Operational Responses to the COVID-19 Pandemic by American Radiation Oncology Practices" @default.
• W3081917032 cites W3014909787 @default.
• W3081917032 cites W3015066898 @default.
• W3081917032 cites W3016170453 @default.
• W3081917032 cites W3018098307 @default.
• W3081917032 cites W3034773963 @default.
• W3081917032 doi "https://doi.org/10.1016/j.ijrobp.2020.06.060" @default.
• W3081917032 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7462779" @default.
• W3081917032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32890512" @default.
• W3081917032 hasPublicationYear "2020" @default.
• W3081917032 type Work @default.
• W3081917032 sameAs 3081917032 @default.
• W3081917032 citedByCount "25" @default.
• W3081917032 countsByYear W30819170322020 @default.
• W3081917032 countsByYear W30819170322021 @default.
• W3081917032 countsByYear W30819170322022 @default.
• W3081917032 countsByYear W30819170322023 @default.
• W3081917032 crossrefType "journal-article" @default.
• W3081917032 hasAuthorship W3081917032A5002414848 @default.
• W3081917032 hasAuthorship W3081917032A5004497069 @default.
• W3081917032 hasAuthorship W3081917032A5005511224 @default.
• W3081917032 hasAuthorship W3081917032A5012879447 @default.
• W3081917032 hasAuthorship W3081917032A5041542657 @default.
• W3081917032 hasAuthorship W3081917032A5044074623 @default.
• W3081917032 hasAuthorship W3081917032A5058872602 @default.
• W3081917032 hasAuthorship W3081917032A5083316273 @default.
• W3081917032 hasAuthorship W3081917032A5085642819 @default.
• W3081917032 hasAuthorship W3081917032A5086367306 @default.
• W3081917032 hasBestOaLocation W30819170321 @default.
• W3081917032 hasConcept C10138342 @default.
• W3081917032 hasConcept C126322002 @default.
• W3081917032 hasConcept C138885662 @default.
• W3081917032 hasConcept C160735492 @default.
• W3081917032 hasConcept C162324750 @default.
• W3081917032 hasConcept C194051981 @default.
• W3081917032 hasConcept C194828623 @default.
• W3081917032 hasConcept C195487862 @default.
• W3081917032 hasConcept C2778137410 @default.
• W3081917032 hasConcept C2779134260 @default.
• W3081917032 hasConcept C2779891985 @default.
• W3081917032 hasConcept C2780668467 @default.
• W3081917032 hasConcept C2992520072 @default.
• W3081917032 hasConcept C3008058167 @default.
• W3081917032 hasConcept C41895202 @default.
• W3081917032 hasConcept C50522688 @default.
• W3081917032 hasConcept C509974204 @default.
• W3081917032 hasConcept C512399662 @default.
• W3081917032 hasConcept C524204448 @default.
• W3081917032 hasConcept C71924100 @default.
• W3081917032 hasConcept C89623803 @default.
• W3081917032 hasConceptScore W3081917032C10138342 @default.
• W3081917032 hasConceptScore W3081917032C126322002 @default.
• W3081917032 hasConceptScore W3081917032C138885662 @default.
• W3081917032 hasConceptScore W3081917032C160735492 @default.
• W3081917032 hasConceptScore W3081917032C162324750 @default.
• W3081917032 hasConceptScore W3081917032C194051981 @default.
• W3081917032 hasConceptScore W3081917032C194828623 @default.
• W3081917032 hasConceptScore W3081917032C195487862 @default.
• W3081917032 hasConceptScore W3081917032C2778137410 @default.
• W3081917032 hasConceptScore W3081917032C2779134260 @default.
• W3081917032 hasConceptScore W3081917032C2779891985 @default.
• W3081917032 hasConceptScore W3081917032C2780668467 @default.
• W3081917032 hasConceptScore W3081917032C2992520072 @default.
• W3081917032 hasConceptScore W3081917032C3008058167 @default.
• W3081917032 hasConceptScore W3081917032C41895202 @default.
• W3081917032 hasConceptScore W3081917032C50522688 @default.
• W3081917032 hasConceptScore W3081917032C509974204 @default.
• W3081917032 hasConceptScore W3081917032C512399662 @default.
• W3081917032 hasConceptScore W3081917032C524204448 @default.
• W3081917032 hasConceptScore W3081917032C71924100 @default.
• W3081917032 hasConceptScore W3081917032C89623803 @default.
• W3081917032 hasIssue "2" @default.
• W3081917032 hasLocation W30819170321 @default.
• W3081917032 hasLocation W30819170322 @default.
• W3081917032 hasOpenAccess W3081917032 @default.
• W3081917032 hasPrimaryLocation W30819170321 @default.
• W3081917032 hasRelatedWork W3014560708 @default.
• W3081917032 hasRelatedWork W3024377520 @default.
• W3081917032 hasRelatedWork W3035060041 @default.
• W3081917032 hasRelatedWork W3036410070 @default.
• W3081917032 hasRelatedWork W3048464972 @default.
• W3081917032 hasRelatedWork W3096745081 @default.
• W3081917032 hasRelatedWork W3120008685 @default.
• W3081917032 hasRelatedWork W3139265257 @default.

• next